Brain scans & smartphones probe Ketamine's Anti-Suicide effect
NCT ID NCT07139106
Summary
This study aims to understand how the drug ketamine might help reduce suicidal thoughts in people with major depression. Researchers will use smartphone apps to track daily stress and brain scans to see how ketamine affects specific brain pathways. The goal is to learn more about the biology behind suicidal thoughts, not to provide a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York State Psychiatric Institute
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.